Schizophrenia Trials in San Diego, United States
Conditions / Schizophrenia / San Diego, United States
Schizophrenia is a medical condition with active clinical research programs worldwide.
217 total trials for this combination
Showing top 10 of 217 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07105111 | A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor | RECRUITING | — |
| NCT05211947 | A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study | TERMINATED | PHASE3 |
| NCT05145413 | A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | COMPLETED | PHASE3 |
| NCT03860597 | Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia | COMPLETED | PHASE4 |
| NCT00034801 | Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia | COMPLETED | PHASE4 |
| NCT06229210 | Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder | RECRUITING | PHASE3 |
| NCT01714713 | A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT01714661 | Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy | COMPLETED | PHASE3 |
| NCT00731549 | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia | COMPLETED | PHASE3 |
| NCT00895258 | Cognitive Training to Improve Work Outcomes in Severe Mental Illness | COMPLETED | PHASE2 |